Biocon has received the EU GMP certification, for its sterile drug product manufacturing facility. The company stated, “We have received the European Union Good Manufacturing Practice...
Biocon has received Establishment Inspection Report (EIR), from the US health regulator for its manufacturing facility in Bengaluru. The EIR is received on closure of...
Biocon Ltd has divested 1.88% stake in its research arm Syngene International, for approx Rs.230 crore. In a regulatory filing the company stated, “Biocon, the promoter...
Biocon’s partner Mylan, has entered into an in-licensing deal to speed up commercialization of biosimilar Humira, developed by Fujifilm Kyowa Kirin Biologics for European markets. Adalimumab...
Biocon has received marketing authorization from the European Commission. Mylan N. V. and Biocon declared that their co-developed biosimilar insulin glargine Semglee, has received marketing authorization...
Biocon has received 6 observations from the US health regulator, after it had inspected its Malaysia manufacturing facility. The company in a regulatory filing stated,...
Biocon has entered into a global partnership with Sandoz, a division of Swiss pharmaceutical Novartis. As per the terms of agreement, both companies will develop,...